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Abstract
Whooping cough, caused by Bordetella pertussis, has resurged and presents a global health burden worldwide. B.
pertussis strains unable to produce the acellular pertussis vaccine component pertactin (Prn), have been emerging and
in some countries represent up to 95% of recent clinical isolates. Knowledge on the effect that Prn deﬁciency has on
infection and immunity to B. pertussis is crucial for the development of new strategies to control this disease. Here, we
characterized the effect of Prn production by B. pertussis on human and murine dendritic cell (DC) maturation as well
as in a murine model for pertussis infection. We incubated human monocyte-derived DCs (moDCs) with multiple
isogenic Prn knockout (Prn-KO) and corresponding parental B. pertussis strains constructed either in laboratory
reference strains with a Tohama I background or in a recently circulating clinical isolate. Results indicate that,
compared to the parental strains, Prn-KO strains induced an increased production of pro-inﬂammatory cytokines by
moDCs. This pro-inﬂammatory phenotype was also observed upon stimulation of murine bone marrow-derived DCs.
Moreover, RNA sequencing analysis of lungs from mice infected with B. pertussis Prn-KO revealed increased expression
of genes involved in cell death. These in vitro and in vivo ﬁndings indicate that B. pertussis strains which do not
produce Prn induce a stronger pro-inﬂammatory response and increased cell death upon infection, suggesting
immunomodulatory properties for Prn.
Introduction
Bordetella pertussis is a Gram-negative respiratory
pathogen that causes pertussis, also known as whooping
cough, a vaccine-preventable disease. Despite high vacci-
nation coverage, pertussis has been re-emerging in many
countries in recent decades and remains a public health
problem1. This highly contagious respiratory disease can
be life threatening in unvaccinated infants and causes
signiﬁcant morbidity across all age groups2. Towards
controlling this disease, two different types of pertussis
vaccines are licensed, namely whole cell vaccines (WCV)
consisting of inactivated bacteria and acellular vaccines
(ACV) consisting of one to ﬁve bacterial antigens3,4. In
the national immunization programs of most Western
countries, including the Netherlands, ACVs have
replaced WCVs to minimize adverse effects5. These
ACVs contain the highly immunogenic virulence factor
pertactin (Prn).
In recent years, the emergence of B. pertussis strains
lacking Prn has been observed, especially in countries
using the ACVs, with the percentage of Prn-deﬁcient
strains rising over time6,7. Prn is a 93 kDa autotransporter
protein of B. pertussis commonly referred to as a minor
adhesion, this however, remains controversial8–10. As for
other autotransporter proteins, Prn is synthesized as a
precursor and further processed to a 30 kDa channel and
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69 kDa passenger domain11. The passenger domain is
transported through the channel across the outer mem-
brane, where it can be displayed at the bacterial surface or
cleaved off. The role of Prn during infection is not fully
understood, nor is the effect that Prn deﬁciency in this
bacterium has on the host immune response. In a pre-
vious study we compared the effect of Prn-producing and
Prn-deﬁcient clinical isolates on human monocyte-
derived dendritic cell (moDC) maturation and found no
differences12. Since we cannot rule out that other muta-
tions in the bacterial genome compensate for the loss of
Prn, comparing the effect of these naturally circulating
B. pertussis strains does not necessarily provide informa-
tion on the effect of Prn only.
Here, we used both human monocyte-derived dendritic
cells (moDCs) and murine bone marrow-derived DCs
(BMDC) incubated with various isogenic parental or Prn
knockout (Prn-KO) B. pertussis strains to characterize the
speciﬁc effect of Prn production by this pathogen on DC
maturation. DC cytokine production, surface marker
expression, and transcriptional proﬁles were analyzed
following bacterial stimulation. In addition to in vitro
studies, we used a murine infection model to investigate
the effect of Prn-deﬁcient B. pertussis strains in vivo. Gene
expression proﬁles in murine lungs and cytokine proﬁles
in sera were determined at two time points post-infection.
Together, these studies show that compared to the iso-
genic parental strains, Prn-KO B. pertussis strains induced
increased production of pro-inﬂammatory cytokines by
DCs and expression of genes involved in cell death upon
murine infection. These ﬁndings indicate that B. pertussis
strains not producing Prn can alter the immune response
to this pathogen.
Results
Characterization of Prn-deﬁcient B. pertussis mutant strains
A whole-cell enzyme-linked immunosorbent assay
(ELISA) was used to determine the production of Prn
and other virulence factors, namely FHA, Ptx, lipooli-
gosaccharide (LOS), Fim2, Fim3, and Vag8, by B0213,
B0213Δprn, B0213REprn, BPSM, BPSMΔprn, B4171,
and B4171Δprn. As expected, Prn was absent in the
three Prn-KO strains (B0213Δprn, BPSMΔprn, and
B4171Δprn). The levels of all other virulence factors
were comparable between parental and mutant strains
(Table 1). The presence/absence of Fim2 or Fim3 cor-
responds to the strain genotype (Table 2). Additionally,
PCR conﬁrmed the prn deﬁciency (Figure S1). More-
over, mutant and parental strains induced similar levels
of TLR2 and TLR4 activation in HEK-Blue reporter
cells, suggesting comparable levels of LOS and lipo-
proteins/lipopeptides on parental and Prn-KO strains
(Fig. 1a, b). Control experiments indicate no activation
of the parental HEK-Null cell line upon stimulation with
the different B. pertussis strains and the activation of
HEK-TLR2 and HEK-TLR4 cells by the corresponding
ligands (Figure S2).
Altogether, the B. pertussis Prn-KOs used in this study,
besides the production of Prn, do not differ from the
isogenic wild type strains in the production of well
characterized bacterial virulence factors.
Table 1 Whole-cell ELISA of B. pertussis virulence factors
Virulence factors
Strains FHA Prn PTX LOS Fim2 Fim3 Vag8
B0213 3.6 0.4 0.5 1.8 1.5 0.1 1.0
B0213Δprn 3.8 0.0 0.5 1.8 1.5 0.1 0.8
B0213REprn 3.4 0.3 0.4 2.0 1.3 0.1 0.8
B4171 2.3 0.3 0.7 1.9 0.1 0.8 1.2
B4171Δprn 1.8 0.0 0.5 2.3 0.1 0.9 1.2
BPSM 1.6 0.3 0.4 2.1 0.7 0.1 1.1
BPSMΔprn 1.6 0.0 0.5 2.1 0.8 0.1 1.4
Table 2 Characteristics of strains used in this study
Strain Genotype Remarks Reference
B0213 ptxP1, ptxA2, prn1,Fim2 Strep resistant Tohama I derivative 14
B0213Δprn ptxP1,ptxA2, prn::kan, Fim2 Prn knock out derived from B0213 13
B0213REprn ptxP1, ptxA2, prn1, Fim2 Restored expression mutant derived from B0213Δprn 13
BPSM ptxP1, ptxA2, prn1, Fim2 Strep resistant Tohama I derivative 15
BPSMΔprn ptxP1,ptxA2,prn::deletion, Fim2 Prn knock out derived from BPSM This study
B4171 ptxP3, ptxA1, prn2 Fim3 Strep resistant 2014 clinical isolate This study
B4171Δprn ptxP3, ptxA1, prn2::kan, Fim3 Prn knock out derived from B4171 This study
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B. pertussis Prn-KO B0213Δprn strain induces enhanced
production of pro-inﬂammatory cytokines by moDC
DCs are important innate immune cells which are
instrumental for the induction of a protective adaptive
immune response13. Human moDCs were used to inves-
tigate the effect of Prn production by B. pertussis on DC
maturation by stimulating them for 48 h with the Tohama
I strain B0213, B0213Δprn, and B0213REprn, in which the
expression of the prn gene was restored. Compared to
moDCs stimulated with the isogenic parental strain,
results indicated that B0213Δprn induced a strong
increase in TNF-α production, as well as a signiﬁcant
increase in IL-6, IL-8, and G-CSF production by moDCs
(Fig. 2a–d). Upon stimulation with the restored mutant
B0213REprn, the production of TNF-α, IL-6, IL-8, and G-
CSF were either fully or partially restored to the levels
induced by the parental strain. Using these three B. per-
tussis strains, we observed no signiﬁcant differences in the
levels of IL-12p70, IL-1β, Eotaxin, IP-10, MIP-1α, MIP-1β,
MCP-1 produced by moDCs (data not shown). Moreover,
ﬂow cytometric analyses indicated only minor changes in
the expression of surface maturation markers CD80,
CD83, and CD86 on moDCs stimulated with the three
different strains (Fig. 2e–g).
B. pertussis B0213Δprn induces distinct gene expression
proﬁle in human DCs
To further characterize the phenotype of the moDCs
induced upon stimulation with B0213, B0213Δprn or
B0213REprn, gene expression levels 6 h post stimulation
were analysed for 84 genes involved in the TLR-pathway
using a qPCR array. A list of all the differently expressed
genes can be found in Table S2, where 2-fold and higher
upregulation and downregulation are marked in red and
blue respectively. A principal component analysis (PCA)
(Fig. 3a) on all 84 genes showed differences in gene
expression proﬁles between medium and B0213 or
B0213Δprn stimulated moDCs. Moreover, the gene
expression induced by the B0213 and B0213REprn strains
is comparable. This suggests that Prn production affects
moDC gene expression. Genes involved in NF-kB sig-
nalling were signiﬁcantly upregulated upon stimulation
with the B0213 strain compared to medium stimulation.
These include IRAK2, MAPK4K, NFKB1/2, NFKBIA, and
REL as well as PTGS2 and TICAM1 (3.4, 7.2, 4.1, 3.5, 19.2,
232.9, and 2.5 fold respectively), which are known to be
upregulated in response to bacterial stimulation14,15. The
CD80 gene expression levels were found to be increased
compared to medium (32.1 fold) and similar among
moDCs stimulated with the three strains, conﬁrming the
obtained ﬂow cytometric data. Moreover, upon stimula-
tion with B0213, moDCs show signiﬁcantly decreased
expression of TLR1, TLR4, TLR5, and TLR6 compared to
medium stimulated moDCs (−12.1, −4.7, −15.7, and −5
fold respectively).
We next focussed on the 36 genes that were sig-
niﬁcantly differently expressed between B0213 and
B0213Δprn stimulated moDCs. The expression of these
genes for all experimental conditions are depicted in a
heat map (Fig. 3b) where, minimum (blue) and maximal
(red) expression values are shown for each gene. Upon
comparison of the gene expression following B0213 or
B0213Δprn stimulation, results corroborate the ﬁndings
on cytokine production (Figure S3); the gene expression
levels of TNF, IL8, and CSF3, encoding for G-CSF, were
signiﬁcantly increased (39.9, 4 and 15.5 fold respectively)
Fig. 1 Characterization of strains used in this study. The different strains used in this study, B0213, B0213Δprn, B0213REprn, BPSM, BPSMΔprn,
B4171, and B4171Δprn (MOI of 40), were used to stimulate HEK-Blue cells either expressing a TLR2 or b TLR4. Activation of these receptors is indicated
as SEAP activity. Medium stimulation is indicated by the dotted line. Ns non-signiﬁcant
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upon moDC stimulation with the B0213Δprn compared
to B0213. Although not signiﬁcant, the expression of the
IL6 also increased (5.7 fold) when moDCs were incubated
with the B0213Δprn compared to B0213. Additionally,
IL1B and IL1A expression (8.3 and 16.2 fold) was sig-
niﬁcantly increased upon stimulation with the B0213Δprn
compared to B0213, as was the expression of IRAK1/2,
JUN, and MAP2K3 (2.1/3.2, 5, and 3.2 fold respectively)
coding for downstream signalling molecules. Moreover,
B0213Δprn induces signiﬁcantly more expression of
TLR1, TLR5, and TLR6 (9.5, 4.7, and 2.4 fold respectively)
and an increasing trend for TLR2 (3.1 fold) compared to
B0213. Together, these data indicate that the lack of Prn
accounts for the increased expression of genes involved in
the production of pro-inﬂammatory cytokines by moDCs.
We also determined the microRNAs (miRNA) expres-
sion of moDCs 24 h post stimulation for all three strains.
For this purpose, we used a custom panel of 39 different
microRNAs that we selected from literature based on
their involvement in DC maturation and/or survival
(Table S1). We found that compared to medium, moDCs
stimulated with B0213 showed signiﬁcantly increased
expression of hsa-miR-132-3p, hsa-miR-144-3p, hsa-miR-
147a, hsa-miR-155-5p, hsa-miR-503-3p, and hsa-miR-
99b-5p and a decreased expression hsa-miR-222-3p
(Fig. 3c). Notably, the expression of hsa-miR-146a-5p
was signiﬁcantly increased by moDCs stimulated with
B0213Δprn (Fig. 3d) but not with B0213 or B0213REprn
(data not shown).
Collectively, these data show a differential gene
expression proﬁle both on mRNA and miRNA level upon
moDC stimulation with B0213Δprn compared to
B0213 stimulation. In line with the observed ﬁndings on
cytokine production, we observed a comparable gene
expression proﬁle between DCs stimulated with B0213
and the restored mutant B0213REprn.
Immunomodulatory effect of Prn deﬁciency is
independent of the B. pertussis strain background
To determine whether a complete deletion of the prn
gene renders comparable results as observed with
B0213Δprn in which the prn gene is interrupted, we
examined the Tohama I derivative BPSM and its Prn-
deﬁcient derivative BPSMΔprn, which has a complete
deletion of the prn gene. We also examined the effect of
another B. pertussis strain, namely B4171 which is a
clinical strain carrying the pertussis toxin promotor allele
(ptxP) 3 isolated in 2014 and its Prn-deﬁcient derivative
Fig. 2 moDC stimulation with B0213Δprn induced increased pro-inﬂammatory cytokine production compared to B0213 or B0213REprn
stimulation. MoDCs were stimulated with B0213, B0213Δprn or B0213REprn at an MOI of 10 or left unstimulated for 48 h. Using luminex, moDC
production of a IL-6, b TNF-α, c IL-8, and d G-CSF in the supernatant and surface expression, using ﬂow cytometry, of e CD80, f CD83, and g CD86
was determined. Experiments were performed using at least three donors *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001, ****P ≤ 0.0001
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Fig. 3 (See legend on next page)
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B4171Δprn. As shown in Fig. 4, moDCs stimulated with
either BPSMΔprn or B4171Δprn also induced increased
production of TNFα and IL-6 compared to moDC sti-
mulated with the isogenic parental strains (Fig. 4a, b),
further supporting the role of Prn in immune
modulation.
Infection with BPSMΔprn induces altered expression
proﬁles in murine lungs
To assess the in vivo relevance of Prn production by B.
pertussis, we ﬁrst determined whether the effect that Prn-
KO strains have on human moDC could also be observed
when using murine BMDCs. To this end, BMDCs were
stimulated for 48 h with either BPSM or BPSMΔprn. As
was observed for human moDCs, results indicated that
compared to BPSM stimulation, BPSMΔprn induces a
strong increase in TNF-α production, as well as a sig-
niﬁcant increase in IL-6, KC/IL-8, and G-CSF production
(Fig. 5a–d). Next, mice were infected with BPSM or
BPSMΔprn or left uninfected as control (Fig. 6a). Using
qPCR with vag8 as a Bordetella-speciﬁc target gene, we
conﬁrm the presence of BPSM or BPSMΔprn in the
murine lungs on day 3 and 7 after infection (Fig. 6b). Sera
and lungs were collected on days 3 and 7 post infection
and used for cytokine determination and gene expression
proﬁling, respectively (Fig. 6a). Although not reaching
statistical signiﬁcance, average serum levels of TNF-α,
KC/IL-8, G-CSF and IL-1β on day 3 post-infection where
higher in BPSMΔprn- compared to BPSM-infected mice
(Fig. 6c–f). No differences in IL-6, IL-17, IFN-y, and IL-5
were observed (Fig. 6g–j). On day 7, we observed a similar
trend as on day 3 for KC/IL-8 (Fig. 6d) and for IFN-y
(Fig. 6i). For all the other cytokines no differences were
observed.
The lung gene expression of control mice and those
infected with either BPSM or BPSMΔprn was additionally
monitored on day 3 and day 7 using RNAseq. Compared
to control mice, lungs of mice infected with BPSM had
6860 genes differentially expressed on day 3 and 7831
genes on day 7. A list of all differentially expressed genes
on both time points can be found in Table S3. As gene
expression proﬁles following B. pertussis infection have
already been extensively described by others16, we focused
on the genes that were differentially expressed in BPSM
versus BPSMΔprn infected mice. On day 3, differential
expression between the groups was identiﬁed for 46
(see ﬁgure on previous page)
Fig. 3 moDC stimulation with B0213Δprn induces a differential gene expression proﬁle compared to B0213 or B0213REprn stimulation.
RNA was isolated 6 h post infection and gene expression of 84 different TLR-pathway associated genes was analysed by means of a a PCA. Moreover,
b the heatmap shows the hierarchical clustering (Pearson’s correlation) of relative expression levels for differentially expressed genes between
medium, B0213, and B0213Δprn stimulated moDC. Relative expression levels for each individual gene are presented as minimum (blue) and
maximum (red). Rows represent gene expression proﬁles of individual samples, 6 h after stimulation. For all samples and all genes included in the
TLR-qPCR array. The expression of various microRNAs by moDCs was determined comparing c parental strain B0213- with medium-stimulated
moDCs as well as d B0213Δprn- with B0213-stimulated moDCs. Experiments were performed using at least three donors. * P ≤ 0.05, **P ≤ 0.01, ***
P ≤ 0.001, ****P ≤ 0.0001
Fig. 4 Prn deﬁciency in different bacterial backgrounds also induced an increased pro-inﬂammatory cytokine proﬁle upon moDC
stimulation. MoDCs were stimulated with BPSM, BPSMΔprn, B4171 or B4171Δprn at an MOI of 10 or left unstimulated for 48 h. MoDC production of
a IL-6 and b TNF-α was determined in the supernatant. Experiments were performed using at least three donors *P ≤ 0.05
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genes. On day 7, 166 differentially expressed genes were
found (Table S4, Fig. 6k). Of these genes, nine were
detected on both days (Fig. 6k). To determine the biolo-
gical processes involved, the differentially expressed genes
were analyzed using Ingenuity Pathway Analysis. By
making use of the ‘Diseases and Functions’ tool we show
compared to BPSM, a signiﬁcant increase in genes (indi-
cated by a z-score of above 2) annotating to the release of
lipids, necrosis, and cell death after infection with
BPSMΔprn on day 7 (Fig. 6l). Additionally, we detected a
decrease in genes annotated to the migration of cells,
almost reaching the z-score cut off of 2 (Fig. 6l).
Altogether, ﬁndings indicate that murine infection
with BPSMΔprn compared to BPSM shows an increas-
ing trend in pro-inﬂammatory cytokine detection in
serum. Moreover, on day 7, genes related to the release
of lipids, necrosis and cell death are increasingly
expressed in the lungs of mice infected with BPSMΔprn
compared to BPSM, indicating that the absence of Prn
in B. pertussis alters the lung gene expression proﬁle of
these animals.
Materials and methods
Ethics statement
This study was conducted according to the principles
described in the Declaration of Helsinki and for the
collection of samples and subsequent analyses, all blood
donors provided written informed consent. Blood sam-
ples were processed anonymously and the research goal,
primary cell isolation, required no review by an accre-
dited Medical Research Ethics Committee (MREC), as
determined by the Dutch Central Committee on
Research involving human subjects (CCMO). Regarding
animal procedures, all experiments were carried out in
accordance with the guidelines of the French Ministry of
Research, and the protocols were approved by the
Ethical Committee of the Region Nord-Pas-de-Calais in
France.
Bacterial strains and growth conditions
Selected B. pertussis strains were inoculated onto Bordet
Gengou (BG) agar plates, supplemented with glycerol and
15% deﬁbrinated sheep blood (BD Biosciences, Franklin
Lakes, New Jersey, USA), and grown at 35 °C and 5% CO2
for 4 days. The strains used in this study are listed in
Table 2. All mutants, with the exception of BPSMΔprn,
were constructed as previously described17. Brieﬂy, the
plasmid pSR2-1.1 was used to introduce the 1 kB kana-
mycin resistance (kan) gene by allelic exchange into prn1
of B021318 (B0213Δprn also known as B1686) and B4171
(B4171Δprn). Also by allelic exchange, pSR2.1 was used to
restore expression of prn (B0213REprn, also known as
B2576) in the B0213Δprn background. The BPSMΔprn
strain was constructed using the suicide vector pSS4940 (a
pSS4245 derivative kindly provided by professor Stibitz)
carrying ﬂanking regions upstream and downstream of
the prn gene, which resulted in a clean deletion of the
entire prn gene (2733 bp) in BPSMB19. Successful deletion
of prn and insertion of the kan gene were conﬁrmed by
PCR (Figure S1). Bacteria used in these experiments were
suspended using a cotton swab in phosphate-buffered
saline (PBS) (Gibco, New York, NY, USA) to collect
bacteria from the BG agar plates. Bacterial concentration
were determined by measuring the optical density (OD) at
600 nm.
Determination of virulence factors produced by the B.
pertussis strains using whole-cell ELISA
To measure the production of various virulence factors
by the different B. pertussis strains, bacterial suspensions
were prepared as described above, and heat inactivated at
56 °C for one hour. A 96 wells Nunc plate (Thermo
Fischer Scientiﬁc, Waltham, MA, USA) was coated with
0.1 OD600 of the indicated bacterial preparations at room
temperature. Control coatings were B. pertussis antigens:
ﬁlamentous hemagglutinin (FHA), Prn, pertussis toxin
(Ptx), LOS and ﬁmbria3 sero-type 2 and 3 (Fim2/3) or
Fig. 5 BPSMΔprn-stimulated murine BMDC show an increased production of pro-inﬂammatory cytokines. Murine BMDCs were stimulated
with BPSM or BPSMΔprn at an MOI of 100 or left unstimulated for 48 h. BMDC production of a TNF-α, b IL-6, c KC/IL-8, and d G-CSF in the supernatant
was determined. Experiments were performed using murine BMDCs from four mice per experimental condition *P ≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001
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Fig. 6 (See legend on next page)
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outer membrane vesicles (OMVs). After overnight incu-
bation at 37 °C, the ELISA was performed using mono-
clonal antibodies directed against Prn20, Ptx, FHA, Vag8,
LOS or Fim2/3 derived from a hybridoma bank21. HRP-
conjugated goat anti-mouse IgG (Southern Biotech, Bri-
mingham, AL, USA) was added and the reaction was
visualized by the addition of chromogenic TMB substrate
(Thermo Fischer Scientiﬁc). The reaction was stopped by
the addition of H2SO4 and absorbance was measured at
450 nm. The presence of B. pertussis antigens from the
different strains are indicated as a ratio that was obtained
by dividing the OD of the strains by the OD of the
respective control antigen. The concentration of the
control antigens used was 0.25 µg/mL for FHA, Prn, Ptx,
LOS, and Fim2/3, giving an OD value of 0.94, 3.04, 1.07,
0.65, 1.42, and 2.84. For Vag8, 1.2 µg/mL OMV was used
as control antigen giving an OD value of 1.16.
Cell lines, culture, and stimulation
Human NF-κB/SEAP reporter HEK293 cells (HEK-
Blue) transfected either with human TLR2 (HEK-Blue-
hTLR2) or human TLR4 (HEK-Blue-hTRL4) in combi-
nation with MD-2 and CD14, as well as untransfected
(HEK-Blue-Null1) cells (InvivoGen, San Diego, CA, USA),
were grown in complete Dulbecco’s modiﬁed Eagle’s
medium (DMEM, Gibco) supplemented with 10% heat-
inactivated fetal calf serum (FCS, Thermo Scientiﬁc), 50
U/mL penicillin (Gibco) and 50 μg/mL streptomycin
(Gibco) (HEK-Blue culture medium) as previously
described with selection antibiotics12. Live bacteria
(multiplicity of infection (MOI) of 40) were used to sti-
mulate 2.5 × 104 HEK-Blue-hTLR2, HEK-Blue-hTLR4, or
HEK-Blue-Null1 cells for 22 h. Supernatant was collected
and secreted embryonic alkaline phosphatase (SEAP)
activity was determined using the QUANTI-Blue assay.
Puriﬁcation, culture, and stimulation of human moDCs
Monocytes were puriﬁed from peripheral blood derived
from healthy donors as described previously22. Brieﬂy,
peripheral blood mononuclear cells were isolated by
Lymphoprep (Nycomed, Zurich, Switzerland) gradient
centrifugation at 1000 × g for 30 min. Subsequently,
monocytes were collected by using MACS in combination
with anti-CD14 microbeads (Miltenyi Biotech, Bergisch
Gladbach, Germany). The isolated cells were 95–99%
CD14+ as determined by ﬂow cytometry. Monocytes
were cultured in 24-well culture plates at 400,000 cells/
well for 6 days at 37 °C in a humidiﬁed atmosphere con-
taining 5% CO2 in Iscove’s Modiﬁed Dulbecco’s Medium
(IMDM) supplemented with 1% FCS, 100 units penicillin,
100 units streptomycin, and 2.92 mg/mL L-glutamine
(Gibco; DC culture medium), 500 U/mL human GM-CSF
(PreproTech, Rocky Hill, NJ, USA) and 800 U/mL human
IL-4 (Active Bioscience, Hamburg, Germany). On day 6,
the immature moDCs were stimulated with the indicated
live B. pertussis (MOI of 10) or left unstimulated in DC
culture medium supplemented with 500 U/mL GM-CSF
or 48 h for cytokine determination or 6/24 h for RNA
isolation. Supernatants were ﬁltered over a 0.22 μm ﬁlter
to remove bacteria before cytokine determination (Milli-
pore, Darmstadt, Germany).
Puriﬁcation, culture, and stimulation of murine BMDCs
BMDCs were isolated as described previously23 with
minor modiﬁcations. In brief, bone marrow was ﬂushed
from the femur and tibia of Balb/c mice (Envigo, Horst,
The Netherlands). Subsequently, cells were passed
through a 70 µm nylon cell strainer, washed and resus-
pended in RPMI 1640 containing 10% FCS, 2mM–L-
glutamine,100 U/mL streptomycin, 100 mg/mL penicillin
(Gibco) and 50 μM β-mercaptoethanol. Cells were seeded
in 6 wells plate at a density of 1 × 106 cells per well in the
presence of 20 ng/mL of murine GM-CSF (Biolegend, San
Diego, CA, USA) and incubated at 37 °C, 5% CO2 for
7 days with fresh mGM-CSF added on day 2 and day 5.
On day 7, cells were stimulated with live B. pertussis
bacteria (MOI of 100) or remained unstimulated for 48 h.
Flow cytometry analysis
Purity of the CD14-positive cells was determined by
staining the monocytes with anti-CD14-PE (BD Bios-
ciences). After 48 h of stimulation, moDCs cells were
washed and resuspended in FACS-buffer (PBS pH 7.2;
0.5% BSA; 0.5 mM EDTA). Subsequently, the cells were
(see ﬁgure on previous page)
Fig. 6 Murine infection with BPSMΔprn results in a different immune response compared to BPSM. a Balb/c mice were infected with 106 CFU
of the parental BPSM, BPSMΔprn or left uninfected as control. Serum for cytokine analysis and lungs for RNA sequencing were collected on day 3 and
day 7 post infection. Bacterial DNA load in the lungs was determined using a b qPCR on the Bordetella-speciﬁc target gene vag8 relative to the
murine household gene ptger2. In serum of BPSM-, BPSMΔprn-infected and control mice, the presence of c TNF-α, d IL-6, e G-CSF, f IL-17, g KC/IL-8, h
IL-1β, i IFN-γ, and j IL-5 was determined on both time points post-infection. k Venn diagram showing the amount of differentially expressed genes on
day 3 and 7 in the lungs of mice infected with BPSMΔprn, as compared to BPSM infected mice, based on averaged normalized gene expression levels
of groups. RNA sequence data on day 7 was analysed using the l diseases or function annotation tool of the software programme Ingenuity from
Qiagen. The animal experiment was performed using six mice per infection group per time point and six control uninfected mice. *P ≤ 0.05, **P ≤
0.01, ***P ≤ 0.001
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stained with a panel of ﬂuorochrome-conjugated mono-
clonal antibodies speciﬁed for moDC maturation (CD80,
CD83, CD86 (BD Biosciences)) and with LIVE/DEAD
Fixable Aqua Dead Cell Stain Kit (Invitrogen, Waltham,
MA, USA) for 30min at 4 °C. Following washing of the
cells and ﬁxation using 1.5% paraformaldehyde (PFA),
cells were acquired on the FACS Canto II (BD Bios-
ciences) and analyzed using FlowJo software (Tree Star,
Ashland, OR, USA).
Animal experiment
Six-week old female Balb/c mice were intranasally
infected with 106 viable BPSM or BPSMΔprn as described
previously24 or received PBS as control (n= 6 per group).
Mice were euthanized either at 3 or 7 days post-infection
and blood was collected prior to harvesting the lungs.
Total blood was left to coagulate and centrifuged at
1000 × g for 5 min to collect sera, which was stored at
−80 °C until further analysis. The left lung lobe was
preserved in RNAlater (Thermo Scientiﬁc) and frozen at
−80 °C for subsequent RNA isolation.
Cytokine measurement by ELISA and luminex
The concentration of various cytokines and chemokines
(IL-1β, IL-6, IL-8, IL-10, IL-12 (p70), G-CSF, TNF-α,
Eotaxin, IP-10, MCP-1 (MCAF), MIP-1α and MIP-1β) in
supernatants of moDC was determined using Bio-plex Pro
cytokine kits (Bio-Rad, Hercules, CA, USA) according to
the manufacturer’s instructions. The presence of TNF-α,
G-CSF, IFN-γ, IL-1β, IL-4, IL-5, IL-6, IL-17, and KC (IL-
8) in supernatants collected from murine BMDCs and
sera was determined using a mouse milliplex MAP kit
(Millipore). Measurements and data analysis were per-
formed with the Bio-Plex 200, using Bio-Plex Manager
software (version 6.1, Bio-Rad Laboratories).
RNA isolation, qPCR, and sequencing
Total RNA was extracted from the moDCs, cultured in
the presence of the indicated stimuli 6 h or 24 h post
stimulation, for messenger RNA (mRNA) or microRNA
(miRNA) analysis respectively. The Phenol extraction
column-based miRNeasy RNA isolation kit (Qiagen,
Venlo, the Netherlands) was used. Murine lung tissue
collected on day 3 and day 7 after infection was homo-
genized by using the FastPrep®-24 bead homogenizer (MP
Biomedicals, Santa Ana, CA, USA) in 700 µL Qiazol
(Qiagen). RNA was isolated according to the manu-
facturer’s instructions with minor modiﬁcations, namely
an extra column-washing step was added using 80%
ethanol before extracting the RNA using RNase-free
water. RNA quality and integrity was determined using
Lab-on-Chip analysis on an Agilent 2100 Bioanalyzer
(Agilent Technologies, Santa Clara, CA, USA). The RNA
integrity numbers (RIN) of all RNA samples were >8.
To measure gene (mRNA) expression of moDCs, cDNA
was synthesized from 200 ng of RNA using the First
strand RT2 kit (Qiagen). The obtained cDNA was used in
combination with the RT2 SYBR Green PCR kit (Qiagen)
for the Toll-Like Receptor signaling pathway RT2 proﬁler
PCR array (#PAHS-018Z, Qiagen) which contains 84
genes involved in TLR-mediated signal transduction and
innate immunity, as well as all necessary controls, using a
StepOnePlus™ Real-Time PCR System (Applied Biosys-
tems, Foster City, CA, USA). For miRNA determination,
cDNA was synthesized from 200 ng of RNA by means of
the miScript II RT kit (Qiagen). The obtained cDNA
was used in combination with the miScript SYBR Green
PCR kit (Qiagen) and the two-step plus qPCR (Applied
Biosystems) to run custom panels of miRNAs
(#CMIHS02331C, Qiagen) containing 39 miRNAs selec-
ted from the literature for miRNAs known to be involved
in DC maturation or survival and all necessary controls.
An overview of the selected miRNAs can be found in
Table S1. Data were analyzed by an online PCR data
analysis platform provided by Qiagen (http://
pcrdataanalysis.saviosciences.com/rna).
In order to conﬁrm the presence of B. pertussis in the
lungs of mice, the gene encoding for the Bordetella spe-
ciﬁc virulence associated gene 8 vag8 was quantiﬁed from
genomic DNA extracted from the lungs of infected and
control mice employing a 7500 Fast thermal cycler using
SYBR Green PCR Master Mix (Applied Biosystems). The
reason why we chose vag8 to detect the presence of B.
pertussis in the lungs of the infected mice is because the
gene for this virulence factor is present in Bordetella spp.
Recently, we have unraveled the underlying mechanisms
of complement evasion by Vag8 of B. pertussis25. Thermal
cycling parameters consisted of 1 min at 50 °C and 10 min
at 95 °C, followed by 40 cycles of 15 s at 95 °C and 1min at
60 °C using the following primers: Vag8-sense (GGT TCA
CTG GTA GAG AGC AC), Vag8-anti-sense (GTT GAG
CAG GGA CAC ATT AC), murine GAPDH-sense (TGC
ACC ACC AAC TGC TTA G) and murine GAPDH-anti-
sense (GGA TGC AGG GAT GAT GTT C). Gene levels
were quantiﬁed according to the following formula: 2-(Cti-
Cta) where Cti the threshold cycle of the gene of interest
and Cta is the threshold cycle of murine GAPDH.
Gene expression proﬁles in the murine lungs were
measured by RNAseq. Libraries for the Illumina platform
were generated using the TruSeq Stranded mRNA Library
Prep Kit using 1 µg of total RNA as input. Brieﬂy, the
mRNA fraction was puriﬁed from total RNA by polyA
capture, fragmented and subjected to ﬁrst-strand cDNA
synthesis with random hexamers in the presence of
Actinomycin D. Second-strand synthesis was performed
incorporating dUTP instead of dTTP. Barcoded DNA
adapters were ligated to both ends of the double-stranded
cDNA and subjected to PCR ampliﬁcation. Libraries were
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subsequently checked on a Bioanalyzer (Agilent) and
quantiﬁed using qPCR with Kapa-kit (Roche, Basel,
Switzerland). The libraries were pooled at equimolar
concentrations and sequenced on an Illumina HiSeq 3000
(single end, 50 bp reads). The sequencing run was ana-
lyzed with the Illumina CASAVA pipeline (v1.8), and
demultiplexed FASTQ ﬁles were generated based on
sample-speciﬁc barcodes (>15 million reads/sample).
RNAseq reads were aligned to the mouse reference gen-
ome (UCSC mm10) and the most recent transcript
annotations using STAR (v.2.5.0b). Expression levels of all
transcripts were quantiﬁed and normalized using Cuf-
ﬂinks (2.1.0) and expressed as Fragments Per Kilobase of
transcript per million mapped reads (FPKM). Differen-
tially expressed genes (DEG) were determined by Cuffdiff
and considered signiﬁcantly different with false discovery
rate (FDR) < 0.1. The data have been deposited in the
National Center for Biotechnical Information Gene
Expression Omnibus (GEO)26 and are accessible through
GEO series with the preliminary accession code
GSE35610. GEO Processes were identiﬁed using Inge-
nuity Pathway Analysis (Build version: 441680M).
Statistical analysis
Statistical signiﬁcance was determined by using
ANOVA followed by unpaired t-tests for the moDC and
BMDC experiments. FDR was controlled at the level of
10% by applying the Benjamini–Hochberg method to the
results of all the tests performed. Results that passed a
selection based on the FDR of 0.1. P-values ≤ 0.05 were
considered statistically signiﬁcant.
Discussion
Whooping cough, caused by the Gram-negative
respiratory pathogen B. pertussis, is a re-emerging dis-
ease. This re-emergence has been attributed to a variety of
factors, including pathogen adaptation that occur most
likely due to vaccination pressure27. For example, the
vaccine strains carry the ptxP2 and ptxP1 alleles as
opposed to the ptxP3 allele which is currently carried by
over 90% of the circulating strains worldwide27. Another
striking and most recent feature is the loss of production
of antigens that are present in the ACV. This is especially
evident for the autotransporter protein Prn. In ACV-using
countries, such as Australia and the United States of
America, over 80% of B. pertussis strains isolated from
patients no longer produce Prn6,28. In The Netherlands,
where the ACV was introduced around 10 years later than
in the United States of America, 15% of the recently iso-
lated strains were reported to be Prn-deﬁcient12. Due to
the association with ACV-usage, Prn deﬁciency may be
the result of the inclusion of the highly immunogenic Prn
antigen in the vaccine29. B. pertussis strains not expressing
one or more of the other vaccine antigens have also been
reported30,31. Nonetheless, these isolates are less com-
monly circulating than the Prn-deﬁcient strains. This
raises questions regarding the function of Prn in B. per-
tussis infection and the effect of Prn-deﬁcient B. pertussis
strains on the immune response.
Studies characterizing immune responses to Prn-
deﬁcient B. pertussis strains are limited and have not
used isogenic strains, a major drawback, making it difﬁ-
cult to uncover the speciﬁc effects of Prn. Most studies are
dedicated to evaluating the ﬁtness of Prn-producing and
Prn-deﬁcient B. pertussis strains during infection of vac-
cinated mice. This has indicated enhanced colonization of
Prn-deﬁcient strains in ACV-immunized mice, suggesting
that the rise of Prn-deﬁcient strains is most probably due
to vaccine pressure29,32. In addition to our recent obser-
vations12, only one more study compared the effect of one
Prn-deﬁcient and a Prn-expressing strain on moDC
maturation33. The authors found no difference in the DC
maturation proﬁle upon stimulation with these B. per-
tussis strains and an increased invasiveness of moDCs by
the Prn-deﬁcient clinical isolate compared to the non-
related reference strain ATCC 97-9733. The latter is a
reference strain known to have an altered LOS structure
which has been associated with decreased TLR4 activa-
tion22. Therefore, the exclusive effect of Prn production
by B. pertussis on moDC activation remains unclear. DCs
will, depending on the mode of activation, produce dif-
ferent cytokines and other immune mediators which will
promote the differentiation of speciﬁc T helper (Th)
responses necessary for protection against pathogens. For
example, the production of IL-12p70 and IL-23 is essen-
tial for differentiation of Th1 and cytotoxic T cells or
Th17 cells respectively and these subsets have been
reported to be important for a protective immune
response against B. pertussis34,35. Therefore, it is impor-
tant to study the effect that different B. pertussis strains
have on DC maturation. To our knowledge, the present
study is the ﬁrst to directly assess the effect that the
absence or presence of Prn production by B. pertussis has
on the DC phenotype using multiple Prn-deﬁcient strains
and their respective isogenic strains.
Our ﬁndings indicate that stimulation of moDCs with B.
pertussis strains deﬁcient in Prn results in an increased
production of pro-inﬂammatory cytokines by these cells.
This DC phenotype was observed when stimulating these
cells with three different Prn-KO strains, either in a
Tohama I as well as in the recent (2014) B. pertussis
clinical isolate B4171 background. These ﬁndings suggest
that Prn has an immunomodulatory function, dampening
the production of pro-inﬂammatory cytokines. Prn pro-
duced by the closely related Bordetella bronchiseptica has
previously been suggested to have an immunomodulatory
role during infection36. Prn of B. pertussis and B.
bronchiseptica have a sequence identity of over 90%
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suggesting that a comparable protein function is highly
probable37.
Expression of 84 genes involved in the TLR signaling
pathway was assessed in moDCs stimulated with B0213,
B0213Δprn or B0213REprn. As expected, the expression
of genes encoding pro-inﬂammatory cytokines was
upregulated in B0213Δprn-stimulated moDCs corrobor-
ating our cytokine production data. Moreover, a differ-
ence was found in the expression of TLRs which were
downregulated upon stimulation with B0213 compared to
the medium control. This is not surprising as TLR
expression in innate cells has been shown to decrease over
time upon microbial stimulation38. This could result in
diminished responsiveness of DCs to microorganisms, a
strategy described for bacteria of the gut microbiota39.
Low levels of TLR2, which can form a heterodimer either
with TLR1 or TLR6, and low levels of TLR5 have been
associated with reduced responsiveness of Langerhans
cells, the DCs of the skin, to bacteria40. Of notice is that
the TLR1, TLR5, TLR6, and TLR2 genes were expressed at
higher levels in B0213Δprn compared to
B0213 stimulated moDCs. Future studies including the
characterization of downstream signalling upon stimula-
tion of DC with these strains may clarify the observed
differences.
In addition to the expression of genes involved in the
TLR pathway, we found that compared to B0213,
B0213Δprn-stimulated moDCs increased their expression
of the miRNA mir-146a-5p. Expression of this miRNA has
been shown to be upregulated by DCs following stimu-
lation with Helicobacter pylori41 and has, in line with our
ﬁndings, been associated with increased pro-inﬂammatory
cytokine secretion42. This miRNA has also been reported
to induce apoptosis in DCs43. Interestingly, our in vivo
experiments do not only show a minor increase of pro-
inﬂammatory cytokines in serum of BPSMΔprn– vs
BPSM-infected mice but more importantly, the analysis of
the RNA sequence data of the murine lungs revealed a
signiﬁcant increase in genes belonging to functional
groups related to cell death. Whether apoptosis and/or
necrosis contribute to the induced cell death remains to
be investigated. As it is difﬁcult to pinpoint which cells are
responsible for these observed effects, one must be cau-
tious to interpret data from a complete organ. We spec-
ulate that the increased induction of pro-inﬂammatory
cytokines by DCs, such as high levels of TNF-α, which can
mediate cell death44, and miRNA146a-5p, could be in
large part responsible for the increased expression of
genes involved in cell death in the murine lungs.
Many pathogens, including B. pertussis, have been
shown to modulate DC responses to enhance bacterial
survival45,46. Different strategies have been described,
including our recent ﬁndings indicating that unlike older
strains, recently circulating Prn producing strains induced
a dominant IL-10 production by moDC12. Here, we made
use of B. pertussis Prn knock-out and respective isogenic
strains, which allowed us to investigate the exclusive effect
of the absence of Prn production by B. pertussis on the
immune response. The data generated suggests an immu-
nomodulatory role for Prn. Unlike the Prn-KO strains used
in this study, Prn-deﬁcient, compared to Prn-producing,
clinical isolates do not appear to differ in their effect on DC
maturation12. It is likely that during the evolutionary pro-
cess towards Prn deﬁciency, other mutations in the bacterial
genome compensate for the loss of Prn. This work sets the
basis for further research directed towards elucidating the
mechanism of action of Prn and identifying these potential
compensating mechanisms of the currently circulating Prn-
deﬁcient B. pertussis strains.
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